Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Platinum-resistant Ovarian Cancer × afuresertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Multiple Myeloma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Platinum-resistant Ovarian Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

anlotinib 2 niraparib 1 afuresertib 1 Paclitaxel 1 PHI-101 1 Gemcitabine 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04374630 2025-09-10

PROFECTA-II

Laekna Limited

Phase 2 Completed

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡